1992
DOI: 10.1097/00000542-199211000-00004
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Trials of an Intravenous Oxygenator in Patients with Adult Respiratory Distress Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
17
0

Year Published

1994
1994
2007
2007

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(20 citation statements)
references
References 0 publications
3
17
0
Order By: Relevance
“…19,20 Early clinical trials of the IVOX in critically ill patients revealed that approximately 25-30% of basal respiratory requirements were achievable, yielding distinct clinical benefit for select patients. [21][22][23][24][25][26] Further technical advances included modifications of fiber material to enhance gas exchange and the incorporation of pumps to promote active mixing. [27][28][29][30][31] In 1994, Conrad et al 32 summarized the findings of a large multinational database, in which 164 IVOX devices were evaluated in 160 patients who were symptomatic while receiving conventional ventilator support for respiratory failure.…”
Section: Discussionmentioning
confidence: 99%
“…19,20 Early clinical trials of the IVOX in critically ill patients revealed that approximately 25-30% of basal respiratory requirements were achievable, yielding distinct clinical benefit for select patients. [21][22][23][24][25][26] Further technical advances included modifications of fiber material to enhance gas exchange and the incorporation of pumps to promote active mixing. [27][28][29][30][31] In 1994, Conrad et al 32 summarized the findings of a large multinational database, in which 164 IVOX devices were evaluated in 160 patients who were symptomatic while receiving conventional ventilator support for respiratory failure.…”
Section: Discussionmentioning
confidence: 99%
“…6,7 The intravenous respiratory assist device introduced by Mortensen proceeded onto human clinical testing in the 1990s as the IVOX and demonstrated general feasibility for the concept of an intravenous respiratory assist device. [3][4][5]8,9 Nevertheless, issues with clinical trial design, the size of the IVOX (33.3F to 45F), 10 and the IVOX level of gas exchange halted further development of the IVOX.…”
mentioning
confidence: 99%
“…In humans, the maximal gas transfer reported is 84 ml路min -1 for O 2 and 82 ml路min -1 for CO 2 with an extreme variability between individuals [7]. In addition, any amelioration due to the IVOX rarely allows ventilatory parameters to be reduced [8].…”
Section: Discussionmentioning
confidence: 99%